术前冷冻神经松解术改善全膝关节置换术后至少12个月的疼痛与功能:一项多中心注册研究
该多中心注册研究纳入356例初次单侧全膝关节置换术患者,其中174例接受术前冷冻神经松解术、182例为对照,随访12个月。冷冻神经松解组疼痛评分(2.0 vs 2.4,P<0.001)、阿片类药物使用率(24% vs 41%,P<0.001)、功能评分(65.2 vs 63.9,P=0.004)及睡眠障碍(52.3 vs 53.3,P<0.001)均优于对照组。作者认为术前冷冻神经松解术与术后12个月阿片依赖减少、疼痛控制改善和睡眠障碍减轻相关,并达到最小临床重要差异。
要点
- 术前冷冻神经松解术与全膝关节置换术后12个月疼痛评分更低相关(2.0 vs 2.4,P<0.001)。
- 术前冷冻神经松解术与术后一年阿片类药物使用率更低相关(24% vs 41%,P<0.001)。
- 术前冷冻神经松解术与功能评分改善(65.2 vs 63.9,P=0.004)及睡眠障碍减轻(52.3 vs 53.3,P<0.001)相关。
核心结论
- 全膝关节置换术前实施冷冻神经松解术与术后12个月阿片依赖减少、疼痛控制改善和睡眠障碍减轻相关,并达到最小临床重要差异。
- 作者指出这些发现重复了其先前分析,并增加了延长随访中持续获益的证据。
研究设计与样本
- 观察性研究,利用Innovations in Genicular Outcomes Research注册数据,识别2021年9月至2024年12月期间接受全膝关节置换术并接受或不接受冷冻神经松解术的患者,随访至术后12个月。
- 共分析356例患者,其中174例接受术前冷冻神经松解术,182例为对照。
- 疼痛采用简明疼痛量表-简表评估,术后阿片类药物使用、睡眠障碍采用患者报告结局测量信息系统问卷评估,身体功能采用膝关节损伤和骨关节炎结局评分-关节置换问卷评估。
- 结局在术前及术后每周、每月和每季度定期评估,比较分析采用广义线性混合效应回归,显著性设定为P<0.05。
主要发现
- 接受冷冻神经松解术的患者疼痛评分显著更低(2.0 vs 2.4,P<0.001)。
- 接受冷冻神经松解术的患者全年阿片类药物使用率降低(24% vs 41%,P<0.001)。
- 接受冷冻神经松解术的患者功能结局优于对照组(膝关节损伤和骨关节炎结局评分-关节置换:65.2 vs 63.9,P=0.004)。
- 冷冻神经松解组睡眠障碍也更低(52.3 vs 53.3,P<0.001)。
临床怎么用
- 原文结论指出全膝关节置换术前实施冷冻神经松解术与术后12个月阿片依赖减少、疼痛控制改善和睡眠障碍减轻相关。
- 原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With the incidence of total knee arthroplasty (TKA) projected to surpass 1.5 million cases annually in the United States by 2050, optimizing perioperative pain control remains a critical priority. This study investigated the effects of preoperative cryoneurolysis in patients undergoing primary unilateral TKA, focusing on 1) pain intensities, 2) opioid utilizations, 3) functional recoveries, and 4) sleep disturbances over 12 months postoperatively. METHODS: This observational study utilized data from the Innovations in Genicular Outcomes Research, identifying patients undergoing TKA who did versus those who did not receive cryoneurolysis from September 2021 to December 2024, and following them for 12 months postoperatively. Of 356 patients analyzed, 174 received preoperative cryoneurolysis and 182 served as controls. Baseline demographics were collected or tabulated. Pain level was quantified using the Brief Pain Inventory-Short Form instrument and postoperative opioid use, with sleep disturbance measured using the Patient-Reported Outcomes Measurement Information System questionnaire. Physical function was assessed by the Knee Injury and Osteoarthritis Outcome Score, joint replacement questionnaire. Outcomes were assessed preoperatively and at regular weekly, monthly, and quarterly intervals postoperatively. Comparative analysis was performed using generalized linear mixed-effects regression, with significance set at P < 0.05. RESULTS: Patients who received cryoneurolysis demonstrated significantly lower pain scores (2.0 versus 2.4, P < 0.001) and reduced opioid utilization across the year (24 versus 41%, P < 0.001). Patients who received cryoneurolysis had improved functional outcomes relative to controls (Knee Injury and Osteoarthritis Outcome Score, joint replacement: 65.2 versus 63.9, P = 0.004). Sleep disturbances were also lower in the cryoneurolysis group (52.3 versus 53.3, P < 0.001). CONCLUSIONS: Cryoneurolysis administered before TKA is associated with reduced long-term opioid dependence, improved pain control, and decreased sleep disturbance for 12 months postoperatively, reaching a minimally clinically important difference. These findings replicate our prior analysis with growing evidence of continued benefit at extended follow-up.
引用
- Ng MK, Lin JH, Spitzer AI, et al. Preoperative Cryoneurolysis Improves Pain and Function for at Least 12 Months after Total Knee Arthroplasty: A Multicenter Registry Study. J Arthroplasty. 2025. PMID: 41093151. doi:10.1016/j.arth.2025.10.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。